Septerna, Inc.
NASDAQ:SEPNBiotechnology
-$0.73 today
- Market cap
- $1.88B
- Beta
- 2.38
- P/E (TTM)
- -43.6
- EPS (TTM)
- -$0.81
Volume 0.30M
Average 0.32M
SEPN Accumulated OCI
Accumulated other comprehensive income: unrealized gains and losses, such as currency translation, recorded outside net income.
Septerna, Inc.NASDAQ: SEPN
Accumulated OCI · Q3 FY2026 · quarter ended Sep 2026
Accumulated OCI turns negative
Q3 FY2026 Accumulated OCI was -$2.05M, compared with $375K a year earlier.
Context
- Accumulated OCI amounted to 0.3% of total assets at the end of Q3 FY2026, up 0.3 pp from a year earlier.
- Accumulated OCI increased in 2 of the last 3 fiscal years.
- FY2025 was the highest annual figure in the 4 fiscal years shown.
What to watch
Whether Accumulated OCI keeps falling in the next quarterly balance sheet after a -645.3% change from a year earlier.
Sources:Balance SheetText generated from reported figures; not investment advice.
Accumulated OCI history
USD · from the balance sheet
- Latest · FY2025
- 617K USD
- Year-over-year change
- +1001.8%
| Period | Period end | Accumulated OCI | YoY change |
|---|---|---|---|
| FY2025 | 2025-12-31 | 617K | +1001.8% |
| FY2024 | 2024-12-31 | 56K | — |
| FY2023 | 2023-12-31 | 0 | — |
| FY2022 | 2022-12-31 | 0 | — |
Accumulated OCI vs competitors
How SEPN compares with its peers on the latest reported figures
- SEPN's Sep 2026 Accumulated OCI of -$2.05M is the 6th highest of the 7 companies compared; the peer median is -$964.5K.
- Its year-over-year change of -645.3% is the highest of 3, against a peer median of -1211.5%.
- Accumulated OCI amounts to 0.3% of total assets for SEPN, versus a peer median of 0.1%.
| Company | Period | Latest balance | YoY | 3-year CAGR | % of assets |
|---|---|---|---|---|---|
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | $0 | — | — | 0.0% | |
| Mar 2026 | -$135K | — | — | 0.0% | |
KLRAKailera Therapeutics, Inc. | Jun 2026 | -$1.79M | — | — | 0.1% |
MBXMBX Biosciences, Inc. Common Stock | Sep 2026 | -$1.96M | -1371.4% | +356.8% | 0.4% |
SEPNSepterna, Inc. | Sep 2026 | -$2.05M | -645.3% | — | 0.3% |
| Jun 2026 | -$3.45M | -1051.7% | — | 0.2% | |
| Peer median (excluding SEPN) | -$964.5K | -1211.5% | +356.8% | 0.1% | |
Competitors are the stored peer set for SEPN. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.
Balance Sheet
Septerna, Inc.
NASDAQ:SEPN
Intrinsic Alpha fair value
Locked
Current Price
$39.45
Unlock the intrinsic value to see where the current price sits on the valuation runway.
Valuation runway
LockedGet the intrinsic value and margin of safety with a free account.
Continue the stock analysis
Jump to another research area for this company.